(Adds analyst comments in paragraphs 4, 6-7) Sept 18 (Reuters) – Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public offerings on Friday, reinforcing
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: ARCHIVE FOOTAGE AND STILL IMAGES OF RETIRED AUSTRLIAN CRICKETER USMAN KHAWAJA / ARCHIVE…
Nov 7 (OPTA) - Results and fixtures for the La Liga on Saturday (start times…
The Colorado Rapids will look to clinch a playoff berth when they visit FC Dallas…
VIDEO SHOWS: ARCHIVE FOOTAGE AND STILL IMAGES OF RETIRED AUSTRLIAN CRICKETER USMAN KHAWAJA / ARCHIVE…
* Attacks strain power, heating systems as temperatures dive * Days ahead of US-brokered three-way…